The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors

The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors

BackgroundNowadays, immune checkpoint inhibitors (ICIs) have become one of the essential immunotherapies for cancer patients. However, the impact of antibiotic (ATB) use on cancer patients treated with ICIs remains controversial.MethodsOur research included retrospective studies and a randomized cli...

Full description

Bibliographic Details
Main Authors: Jiaxin Zhou, Guowei Huang, Wan-Ching Wong, Da-hai Hu, Jie-wen Zhu, Ruiman Li, Hong Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
antibiotic
immune checkpoint inhibitor
PD-1
PD-L1
survival outcomes
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.968729/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.968729/full

Similar Items